← Back to Boehringer Ingelheim International GmbH
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19542772 | ANTI-INTERLEUKIN-11 ANTIBODIES AND METHODS OF USE THEREOF | DEBERRY, REGINA M | 1647 | §112 | Non-Final OA | — | Pending | Feb 18, 2026 |
| 18989164 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | GREENE, IVAN A | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18872318 | HSD17B13 INHIBITORS | SAEED, KAMAL A | 1626 | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18951962 | GPR88-RECEPTOR-AGONIST | WHITE, DAWANNA SHAR-DAY | 1627 | §112 | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18947116 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | KIM, SEONG JONG | 1621 | §102§103DP | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18848533 | NEW GLUTAMINE SYNTHETASE VARIANTS AS SELECTION MARKER | NOAKES, SUZANNE MARIE | 1656 | §102§112 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18808311 | BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATMENT OF EYE DISEASES | GAO, ASHLEY HARTMAN | 1678 | §103§112 | Non-Final OA | — | Pending | Aug 19, 2024 |
| 18801886 | Cardiosafe Antidiabetic Therapy | BAEK, BONG-SOOK | 1611 | §102§103Other | Final Rejection | — | Pending | Aug 13, 2024 |
| 18800173 | CARDIO- AND RENOSAFE ANTIDIABETIC THERAPY | KOSTURKO, GEORGE W | 1621 | §102DP | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18798981 | ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF NEUTROPHILIC DERMATOSES | BUNNER, BRIDGET E | 1647 | §103 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18789815 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | MCKOY, QUINCY ANDRE | 1626 | DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18789814 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | NOTTINGHAM, KYLE GREGORY | 1621 | §112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18785078 | PROCESS FOR THE MANUFACTURE OF A HER2 INHIBITOR | OTTON, ALICIA L | 1699 | §112 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18728837 | METHOD FOR STRUCTURE ELUCIDATION | MITCHELL, NATHAN A | 2857 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18746567 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | LOVE, TREVOR M | 1611 | §103 | Final Rejection | 28d overdue | Pending | Jun 18, 2024 |
| 18706144 | HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS | RICCI, CRAIG D | 1611 | §112 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18700748 | TRPC6 INHIBITORY COMPOUNDS FOR TREATING SEPSIS | CHENG, KAREN | 1623 | §103§112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18695414 | QUANTIFICATION METHOD OF POLYSORBATE IN AQUEOUS FORMULATIONS | SODERQUIST, ARLEN | 1797 | §102§103§112 | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18691241 | MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE | BURKETT, DANIEL JOHN | 1624 | §112DP | Final Rejection | — | Pending | Mar 12, 2024 |
| 18597314 | METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT | BERRY, LAYLA D | 1693 | §103 | Final Rejection | 66d overdue | Pending | Mar 06, 2024 |
| 18589552 | New therapeutic combinations for the treatment of Progressive Fibrosing interstitial lung diseases | HAVLIN, ROBERT H | 1626 | §103§112Other | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18686991 | METHOD OF DETERMINING A FUTURE COLOR VALUE OR CORRESPONDING PROPERTY AND ARRANGEMENT THEREFOR | GUTIERREZ, GISSELLE M | 2884 | §112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18585280 | New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases | HAVLIN, ROBERT H | 1626 | §103Other | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18423352 | ANTI-SEMA3A ANTIBODIES AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES | FONTAINHAS, AURORA M | 1675 | §102§112DP | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18579526 | IDENTIFICATION OF COMMON TUMOR-SPECIFIC T CELL RECEPTORS AND ANTIGENS | LANDSMAN, ROBERT S | 1647 | §103§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18391748 | CRYSTALLINE FORM OF AN MDM2-p53 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18389892 | GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS | MIKNIS, ZACHARY J | 1658 | §112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18544532 | SOLID DISPERSION OF A HER2 INHIBITOR | HIRT, ERIN E | 1616 | §103§112Other | Final Rejection | 26d | Pending | Dec 19, 2023 |
| 18542910 | PHENYLPIPERIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | ONDACHI, PAULINE WANJIKU MUCH | 1627 | §103§112 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18561823 | A METHOD AND SYSTEM FOR INTEGRATED AND CONTINUOUS VIRAL FILTRATION, CONCENTRATION AND BUFFER EXCHANGE | MOAZZAMI, NAGHMEH NINA | 1652 | §102§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18561842 | TITER METHOD USING UV MEASUREMENT FOR CONTINUOUS BIOLOGICAL PRODUCTION | LEE, BYUNG RO | 2858 | §101§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18493126 | HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING | BARSKY, JARED | 1628 | DP | Final Rejection | — | Pending | Oct 24, 2023 |
| 18554231 | ANTICANCER THERAPY | JARRELL, NOBLE E | 1699 | §103§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18474419 | Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitor | MACFARLANE, STACEY NEE | 1675 | §101§112 | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18551553 | Pharmaceutical Combinations for Treating Cancer | DRISCOLL, MAUREEN VARINA | 1644 | §112DP | Final Rejection | — | Pending | Sep 20, 2023 |
| 18461850 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | CRAIGO, BAHAR ALAWI | 1699 | DP | Final Rejection | — | Pending | Sep 06, 2023 |
| 18450487 | COMBINATION THERAPY COMPRISING LONG ACTING GLP-1/GLUCAGON AND NPY2 RECEPTOR AGONISTS | JAUHARI, SACHI | 1654 | §103Other | Final Rejection | 55d | Pending | Aug 16, 2023 |
| 18275616 | ANTI-IL1RAP ANTIBODIES | NICKOL, GARY B | 1643 | §102§112 | Non-Final OA | — | Pending | Aug 03, 2023 |
| 18362034 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | BARSKY, JARED | 1628 | Other | Final Rejection | 26d overdue | Pending | Jul 31, 2023 |
| 18353133 | ANTI-IL-36R ANTIBODY FORMULATIONS | MCCOLLUM, ANDREA K | 1674 | §103§112Other | Non-Final OA | 44d overdue | Pending | Jul 17, 2023 |
| 18259098 | VIRAL CAPSID PROTEINS WITH SPECIFICITY TO HEART TISSUE CELLS | GIBBS, TERRA C | 1635 | §103§112 | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18267795 | BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES | ROONEY, NORA MAUREEN | 1641 | §102§103§112Other | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18334454 | PERFUSION MEDIUM | BARRON, SEAN C | 1653 | §103 | Final Rejection | 70d | Pending | Jun 14, 2023 |
| 18256777 | FORMULATION FOR MULTI-PURPOSE APPLICATION | LU, CHENG | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18327255 | HUMAN ANTIBODIES TO TN ANTIGEN | MIDDLETON, DANAYA L | 1618 | §112 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18039433 | ADMINISTRATION DEVICE FOR IN PARTICULAR INTRAVITREAL ADMINISTRATION OF A FLUID | BRANDT, DAVID NELSON | 3783 | §102§103§112 | Final Rejection | 30d | Pending | May 30, 2023 |
| 18251562 | VIRAL VECTORS AND NUCLEIC ACIDS FOR USE IN THE TREATMENT OF ILD, PF-ILD AND IPF | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | May 03, 2023 |
| 18032634 | ADMINISTRATION DEVICE FOR IN PARTICULAR INTRAVITREAL ADMINISTRATION OF A FLUID | BOSQUES, EDELMIRA | 3772 | §102 | Final Rejection | — | Pending | Apr 19, 2023 |
| 18145234 | MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN | ANGELL, JON E | 1637 | §112Other | Non-Final OA | — | Pending | Dec 22, 2022 |
| 17759056 | MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING FIBROSIS, HYPERTROPHY OR HEART FAILURE | BORGEEST, CHRISTINA M | 1675 | §103Other | Non-Final OA | — | Pending | Jul 19, 2022 |
| 17785427 | BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT | DONOGHUE, BRITTNEY ERIN | 1675 | §103§112DP | Non-Final OA | — | Pending | Jun 15, 2022 |
| 17763723 | CONCENTRATED PERFUSION MEDIUM | MOSS, NATALIE M | 1653 | §103§112 | Non-Final OA | — | Pending | Mar 25, 2022 |
| 17686880 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | TIEN, LUCY MINYU | 1612 | §103§112DP | Final Rejection | 56d overdue | Pending | Mar 04, 2022 |
| 17530559 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | KASSA, TIGABU | 1619 | §103 | Final Rejection | 72d overdue | Pending | Nov 19, 2021 |
| 17212456 | IL-11 ANTIBODIES | MIDDLETON, DANAYA L | 1674 | §112 | Non-Final OA | — | Pending | Mar 25, 2021 |
| 13885646 | AGENTS AND METHODS FOR TREATING DISEASES THAT CORRELATE WITH BCMA EXPRESSION | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Jul 08, 2013 |
| 19068745 | ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Non-Final OA | — | Pending | Mar 03, 2025 |
| 18666922 | Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan | SHIAO, YIH-HORNG | 1691 | §102§112DP | Non-Final OA | — | Pending | May 17, 2024 |
| 18594627 | SYSTEMS AND METHODS FOR DELIVERY OF LIQUID PHARMACEUTICAL COMPOSITIONS IN PARTICULAR COMPRISING ONE OR MORE SGLT-2 INHIBITOR(S) | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18578118 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112 | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18537432 | SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS | BREDEFELD, RACHAEL EVA | 3786 | §103§112 | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18252590 | NEW FELINE HERPES VIRUS VACCINE | ALLEN, MICHAEL D | 1671 | §112 | Non-Final OA | — | Pending | May 11, 2023 |
| 17070968 | EXAMINATION APPARATUS FOR MEDICAL EXAMINATION OF AN ANIMAL | HADDAD, MOUSSA MAHER | 3796 | §103§112 | Final Rejection | — | Pending | Oct 15, 2020 |
| 19054649 | ATTENUATED BORDETELLA BRONCHISEPTICA STRAINS, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS, AND METHODS OF MAKING & USE THEREOF | GRASER, JENNIFER E | 1645 | §102§103§112 | Non-Final OA | — | Pending | Feb 14, 2025 |
| 18003056 | COMBINATION PORCINE VACCINE | FOLEY, SHANON A | 1671 | §103 | Non-Final OA | 31d overdue | Pending | Dec 22, 2022 |
